Head-to-head comparison of tirzepatide and semaglutide for weight loss: A systematic review and meta-analysis
{{output}}
Background: Both tirzepatide and semaglutide, once-weekly injectable incretin-based agents, have demonstrated substantial weight-reducing potential in populations with overweight or obesity. However, the relative effectiveness of... ...
